Johnson & Johnson-backed surgical technology developer Cardiac Dimensions has now raised more than $172m altogether.

Cardiac Dimensions, a US-based cardiac surgery device developer backed by pharmaceutical firm Johnson & Johnson and financial services group Mitsubishi UFJ Financial, has raised $17.5m in its series C round.

All the company’s existing shareholders participated in the round, which included Aperture Venture Partners, Arboretum Ventures, Hostplus, Life Sciences Partners, Lumira Ventures, and MH Carnegie.

The company closed a $39m series B round in April 2018 featuring Arboretum Ventures, Lumira Capital, Hostplus, LSP, Aperture Venture Partners, MH Carnegie and venture…

James Mawson

James Mawson is founder and chief executive of Global Venturing.